<code id='782D4D57D9'></code><style id='782D4D57D9'></style>
    • <acronym id='782D4D57D9'></acronym>
      <center id='782D4D57D9'><center id='782D4D57D9'><tfoot id='782D4D57D9'></tfoot></center><abbr id='782D4D57D9'><dir id='782D4D57D9'><tfoot id='782D4D57D9'></tfoot><noframes id='782D4D57D9'>

    • <optgroup id='782D4D57D9'><strike id='782D4D57D9'><sup id='782D4D57D9'></sup></strike><code id='782D4D57D9'></code></optgroup>
        1. <b id='782D4D57D9'><label id='782D4D57D9'><select id='782D4D57D9'><dt id='782D4D57D9'><span id='782D4D57D9'></span></dt></select></label></b><u id='782D4D57D9'></u>
          <i id='782D4D57D9'><strike id='782D4D57D9'><tt id='782D4D57D9'><pre id='782D4D57D9'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:7
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc
          JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          UCB departs biotech trade group BIO

          AdobeWASHINGTON— UCBleftBIOattheendof2023,thesecondmajormembercompanytoexitafterPfizerpulledoutaswel